ITRMF — Iterum Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Iterum Therapeutics Reports First Quarter 2022 Financial Results
Brief: Iterum Therapeutics Provides Regulatory Update
Iterum Therapeutics PLC expected to post a loss of 5 cents a share - Earnings Preview
Brief: Iterum Therapeutics Reports Q4 Results
Iterum Therapeutics PLC reports results for the quarter ended in December - Earnings Summary
Iterum Therapeutics PLC expected to post a loss of 4 cents a share - Earnings Preview
Brief: Iterum Therapeutics Granted 180-Day Extension By Nasdaq To Regain Compliance With Bid Price Rule
Iterum Therapeutics PLC expected to post a loss of 4 cents a share - Earnings Preview
Iterum Therapeutics PLC reports results for the quarter ended in September - Earnings Summary
Brief: Iterum Therapeutics Reports Q3 Net Income Of $3.7 Mln
Iterum Therapeutics PLC expected to post earnings of 12 cents a share - Earnings Preview
Iterum rises on successful FDA meeting for oral UTI treatment
Brief: Iterum Therapeutics Provides Update From FDA Type A Meeting Regarding Oral Sulopenem
Brief: Iterum Therapeutics PLC Says On Sept 7, Received A Letter From Nasdaq That Co Was Not In Compliance With Nasdaq Listing Rule
Brief: Iterum Therapeutics Reports Second Quarter 2021 Financial Results
Iterum Therapeutics PLC expected to post a loss of 6 cents a share - Earnings Preview
Iterum Therapeutics PLC expected to post a loss of 6 cents a share - Earnings Preview
Iterum Therapeutics PLC expected to post a loss of 6 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Gaotu Techedu, Alibaba Holding, Weibo, Iterum